A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients
N. LE-DONG (Erpent, Belgium), T. Hua-Huy (Paris, France), T. Hoang-Thi (Paris, France), V. Codullo (Paris, France), Y. Allanore (Paris, France), A. Dinh-Xuan (Paris, France)
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. LE-DONG (Erpent, Belgium), T. Hua-Huy (Paris, France), T. Hoang-Thi (Paris, France), V. Codullo (Paris, France), Y. Allanore (Paris, France), A. Dinh-Xuan (Paris, France). A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients. 807
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: